{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:15:04Z","timestamp":1740107704025,"version":"3.37.3"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T00:00:00Z","timestamp":1521072000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s10067-018-4065-7","type":"journal-article","created":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T21:40:00Z","timestamp":1522791600000},"page":"1885-1894","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Improvement in OMERACT domains and renal function with regular treatment for gout: a 12-month follow-up cohort study"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6636-2301","authenticated-orcid":false,"given":"Janitzia","family":"Vazquez-Mellado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingris","family":"Pel\u00e1ez-Ballestas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rub\u00e9n","family":"Burgos-Vargas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Everardo","family":"Alvarez-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Garc\u00eda-M\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Pascual-Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Rull-Gabayet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,15]]},"reference":[{"key":"4065_CR1","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1136\/annrheumdis-2013-204463","volume":"74","author":"CF Kuo","year":"2015","unstructured":"Kuo CF, Grainge MJ, Mallen C, Zhang W, Doherty M (2015) Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study. Ann Rheum Dis 74:661\u2013667","journal-title":"Ann Rheum Dis"},{"key":"4065_CR2","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1097\/BOR.0000000000000168","volume":"27","author":"E Wise","year":"2015","unstructured":"Wise E, Khanna PP (2015) The impact of gout guidelines. Curr Op Rheumatol 27:225\u2013230","journal-title":"Curr Op Rheumatol"},{"key":"4065_CR3","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.3899\/jrheum.110272","volume":"38","author":"N Dalbeth","year":"2011","unstructured":"Dalbeth N, McQueen FM, Singh JA et al (2011) Tophus measurement as an outcome measure for clinical trials of chronic gout: progress and research priorities. J Rheumatol 38:1458\u20131461","journal-title":"J Rheumatol"},{"key":"4065_CR4","first-page":"2452","volume":"32","author":"HR Schumacher Jr","year":"2005","unstructured":"Schumacher HR Jr, Edwards LN, Perez-Ruiz F et al (2005) OMERACT 7 special interest group. Outcome measures for acute and chronic gout. J Rheumatol 32:2452\u20132455","journal-title":"J Rheumatol"},{"key":"4065_CR5","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1136\/ard.2007.079970","volume":"67","author":"WJ Taylor","year":"2008","unstructured":"Taylor WJ, Schumacher HR Jr, Baraf HS et al (2008) A modified Delphi exercise to determine the extent of consensus with OMERACT outcome domains for studies of acute and chronic gout. Ann Rheum Dis 67:888\u2013891","journal-title":"Ann Rheum Dis"},{"key":"4065_CR6","first-page":"1381","volume":"34","author":"HR Schumacher","year":"2007","unstructured":"Schumacher HR, Taylor W, Joseph-Ridge N, Perez-Ruiz F, Chen LX, Schlesinger N, Khanna D, Furst DE, Becker MA, Dalbeth N, Edwards NL (2007) Outcome evaluations in gout. J Rheumatol 34:1381\u20131385","journal-title":"J Rheumatol"},{"key":"4065_CR7","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3899\/jrheum.090370","volume":"36","author":"HR Schumacher","year":"2009","unstructured":"Schumacher HR, Taylor W, Edwards L et al (2009) Outcome domains for studies of acute and chronic gout. J Rheumatol 36:342\u2013345","journal-title":"J Rheumatol"},{"key":"4065_CR8","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.3899\/jrheum.110271","volume":"38","author":"JA Singh","year":"2011","unstructured":"Singh JA, Taylor WJ, Simon LS et al (2011) Patient-reported outcomes in chronic gout: a report from OMERACT 10. J Rheumatol 38:1452\u20131457","journal-title":"J Rheumatol"},{"key":"4065_CR9","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.3899\/jrheum.110274","volume":"38","author":"WJ Taylor","year":"2011","unstructured":"Taylor WJ, Singh JA, Saag KG et al (2011) Bringing it all together: a novel approach to the development of response criteria for chronic gout clinical trials. J Rheumatol 38:1467\u20131470","journal-title":"J Rheumatol"},{"key":"4065_CR10","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1002\/acr.21955","volume":"65","author":"WJ Taylor","year":"2013","unstructured":"Taylor WJ, Brown M, Aati O, Weatherall M, Dalbeth N (2013) Do patient preferences for core outcome domains for chronic gout studies support the validity of composite response criteria? Arthritis Care Res 65:1259\u20131264","journal-title":"Arthritis Care Res"},{"key":"4065_CR11","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1097\/RHU.0000000000000090","volume":"20","author":"C Diaz-Torne","year":"2014","unstructured":"Diaz-Torne C, Pou MA, Castellvi I, Corominas H, Taylor WJ (2014) Concerns of patients with gout are incompletely captured by OMERACT-endorsed domains of measurement for chronic gout studies. J Clin Rheumatol 20:138\u2013140","journal-title":"J Clin Rheumatol"},{"key":"4065_CR12","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/art.1780200320","volume":"20","author":"SL Wallace","year":"1977","unstructured":"Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Y\u00fc TF (1977) Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 20:895\u2013900","journal-title":"Arthritis Rheum"},{"key":"4065_CR13","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s10067-011-1873-4","volume":"31","author":"J V\u00e1zquez-Mellado","year":"2012","unstructured":"V\u00e1zquez-Mellado J, Hern\u00e1ndez-Cuevas CB, Alvarez-Hern\u00e1ndez E, Ventura-Rios L, Pel\u00e1ez-Ballestas I, Casasola-Vargas J, Garc\u00eda-M\u00e9ndez S, Burgos-Vargas R (2012) The diagnostic value of the proposal for clinical gout diagnosis (CGD). Clin Rheumatol 31:429\u2013434","journal-title":"Clin Rheumatol"},{"key":"4065_CR14","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1002\/art.39254","volume":"67","author":"T Neogi","year":"2015","unstructured":"Neogi T, Jansen TL, Dalbeth N et al (2015) 2015 gout classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheumatol 67:2557\u20132568","journal-title":"Arthritis Rheumatol"},{"key":"4065_CR15","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S0212-6567(01)70406-4","volume":"28","author":"M Herdman","year":"2001","unstructured":"Herdman M, Bad\u00eda X, Berra S (2001) EuroQol-5D: a simple alternative for measuring health-related quality of life in primary care. Aten Primaria 28:425\u2013430","journal-title":"Aten Primaria"},{"key":"4065_CR16","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/art.23575","volume":"15","author":"E Alvarez-Hern\u00e1ndez","year":"2008","unstructured":"Alvarez-Hern\u00e1ndez E, Pel\u00e1ez-Ballestas I, V\u00e1zquez-Mellado J et al (2008) Validation of the health assessment questionnaire disability index in patients with gout. Arthritis Rheum 15:665\u2013669","journal-title":"Arthritis Rheum"},{"key":"4065_CR17","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","author":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults","year":"2001","unstructured":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 285:2486\u20132497","journal-title":"JAMA"},{"key":"4065_CR18","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/1753-0407.12524","volume":"9","author":"PH Marathe","year":"2017","unstructured":"Marathe PH, Gao HX, Close KL (2017) American Diabetes Association standards of medical Care in Diabetes 2017. J Diabetes 9:320\u2013324","journal-title":"J Diabetes"},{"key":"4065_CR19","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 130:461\u2013470","journal-title":"Ann Intern Med"},{"key":"4065_CR20","first-page":"1","volume":"3","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2012","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group (2012) KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3:1\u2013150","journal-title":"Kidney Int Suppl"},{"key":"4065_CR21","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1002\/acr.21772","volume":"64","author":"D Khanna","year":"2012","unstructured":"Khanna D, Fitzgerald JD, Khanna PP, Bae S, Singh MK, Neogi T, Pillinger MH, Merill J, Lee S, Prakash S, Kaldas M, Gogia M, Perez-Ruiz F, Taylor W, Liot\u00e9 F, Choi H, Singh JA, Dalbeth N, Kaplan S, Niyyar V, Jones D, Yarows SA, Roessler B, Kerr G, King C, Levy G, Furst DE, Edwards NL, Mandell B, Schumacher HR, Robbins M, Wenger N, Terkeltaub R, American College of Rheumatology (2012) 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res 64:1431\u20131446","journal-title":"Arthritis Care Res"},{"key":"4065_CR22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","volume":"76","author":"P Richette","year":"2017","unstructured":"Richette P, Doherty M, Pascual E, Barskova V, Becce F, Casta\u00f1eda-Sanabria J, Coyfish M, Guillo S, Jansen TL, Janssens H, Liot\u00e9 F, Mallen C, Nuki G, Perez-Ruiz F, Pimentao J, Punzi L, Pywell T, So A, Tausche AK, Uhlig T, Zavada J, Zhang W, Tubach F, Bardin T (2017) 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis 76:29\u201342","journal-title":"Ann Rheum Dis"},{"key":"4065_CR23","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S0895-4356(99)00206-1","volume":"53","author":"JA Husted","year":"2000","unstructured":"Husted JA, Cook RJ, Farewell VT, Gladman D (2000) Methods for assessing responsiveness a critical review and recommendations. J Clin Epidemiol 53:459\u2013468","journal-title":"J Clin Epidemiol"},{"key":"4065_CR24","doi-asserted-by":"publisher","first-page":"e935","DOI":"10.1097\/MD.0000000000000935","volume":"94","author":"S Garc\u00eda-M\u00e9ndez","year":"2015","unstructured":"Garc\u00eda-M\u00e9ndez S, Rivera-Bahena CB, Montiel-Hern\u00e1ndez JL et al (2015) A Prospective follow-up of adipocytokines in cohort patients with gout. Association with metabolic syndrome but not with clinical inflammatory findings: strobe-compliant article. Medicine 94:e935","journal-title":"Medicine"},{"key":"4065_CR25","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1002\/art.22232","volume":"55","author":"F P\u00e9rez Ruiz","year":"2006","unstructured":"P\u00e9rez Ruiz F, Atxotegi J, Hernado I, Calabozo M, Nolla JM (2006) Using serum urate levels to determine the period free of gout symptoms after withdrawal of long-term urate-lowering therapy: a prospective study. Arthritis Rheum 55:786\u2013790","journal-title":"Arthritis Rheum"},{"key":"4065_CR26","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1002\/art.23007","volume":"57","author":"F Perez Ruiz","year":"2007","unstructured":"Perez Ruiz F, Liot\u00e9 F (2007) Lowering serum uric acid levels: what is the optimal target for improving clinical outcomes in gout? Arthritis Rheum 57:1324\u20131328","journal-title":"Arthritis Rheum"},{"key":"4065_CR27","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1136\/annrheumdis-2012-202594","volume":"72","author":"E Pascual","year":"2013","unstructured":"Pascual E, Andr\u00e9s M, Vela P (2013) Gout treatment: should we aim for rapid crystal dissolution? Ann Rheum Dis 72:635\u2013637","journal-title":"Ann Rheum Dis"},{"key":"4065_CR28","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.3899\/jrheum.110273","volume":"38","author":"LK Stamp","year":"2011","unstructured":"Stamp LK, Khanna PJ, Dalbeth N et al (2011) Serum urate in chronic gout\u2014will it be the first validated soluble biomarker in rheumatology? J Rheumatol 38:1462\u20132466","journal-title":"J Rheumatol"},{"key":"4065_CR29","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1111\/1756-185X.13032","volume":"20","author":"EJ Corbett","year":"2017","unstructured":"Corbett EJ, Pentony P, McGill NW (2017) Achieving serum urate targets in gout and audit in a gout-oriented rheumatology practice. Int J Rheum Dis 20:894\u2013897","journal-title":"Int J Rheum Dis"},{"key":"4065_CR30","first-page":"1","volume":"11","author":"O Slot","year":"2017","unstructured":"Slot O (2017) Gout in a rheumatology clinic: results of EULAR\/ACR guidelines compliant treatment. Scand J Rheumatol 11:1\u20134","journal-title":"Scand J Rheumatol"},{"key":"4065_CR31","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/art.39840","volume":"69","author":"K Saag","year":"2017","unstructured":"Saag K, Fitz-Patrick D, Kopicko J et al (2017) Lesinurad combined with allopurinol: a randomized, double-blind, placebo-controlled study in gout patients with an inadequate response to standard-of-care allopurinol (a US-based study). Arthritis Rheumatol 69:203\u2013212","journal-title":"Arthritis Rheumatol"},{"key":"4065_CR32","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1177\/1060028016679848","volume":"51","author":"JC Hughes","year":"2017","unstructured":"Hughes JC, Wallace JL, Bryant CL, Salvig BE, Fourakre TN, Stone WJ (2017) Monitoring of Urate-lowering therapy among US veterans following the 2012 American College of Rheumatology Guidelines for Management of Gout. Ann Pharmacother 51:301\u2013306","journal-title":"Ann Pharmacother"},{"key":"4065_CR33","volume":"94","author":"I Pel\u00e1ez-Ballestas","year":"2015","unstructured":"Pel\u00e1ez-Ballestas I, Boonen A, V\u00e1zquez-Mellado J et al (2015) Coping strategies for health and daily-life stressors in patients with rheumatoid arthritis, ankylosing spondylitis, and gout: STROBE-compliant article. REUMAIMPACT Group Med 94:e600","journal-title":"REUMAIMPACT Group Med"},{"key":"4065_CR34","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s10067-016-3381-z","volume":"36","author":"CO L\u00f3pez L\u00f3pez","year":"2017","unstructured":"L\u00f3pez L\u00f3pez CO, Lugo EF, Alvarez-Hern\u00e1ndez E, Pel\u00e1ez-Ballestas I, Burgos-Vargas R, V\u00e1zquez-Mellado J (2017) Severe tophaceous gout and disability: changes in the past 15 years. Clin Rheumatol 36:199\u2013204","journal-title":"Clin Rheumatol"},{"key":"4065_CR35","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1136\/annrheumdis-2016-209467","volume":"76","author":"U Kiltz","year":"2017","unstructured":"Kiltz U, Smolen J, Bardin T, Cohen Solal A, Dalbeth N, Doherty M, Engel B, Flader C, Kay J, Matsuoka M, Perez-Ruiz F, da Rocha Castelar-Pinheiro G, Saag K, So A, Vazquez Mellado J, Weisman M, Westhoff TH, Yamanaka H, Braun J (2017) Treat to target (T2T) recommendations for gout. Ann Rheum Dis 76:632\u2013638","journal-title":"Ann Rheum Dis"},{"key":"4065_CR36","doi-asserted-by":"publisher","first-page":"37","DOI":"10.7326\/M16-0461","volume":"166","author":"PG Shekelle","year":"2017","unstructured":"Shekelle PG, Newberry J, Fitzgerald JD et al (2017) Management of gout: a systematic review in support of an American College of Physicians Clinical Practice Guideline. Ann Intern Med 166:37\u201351","journal-title":"Ann Intern Med"},{"key":"4065_CR37","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1002\/art.40031","volume":"69","author":"JD Fitzgerald","year":"2017","unstructured":"Fitzgerald JD, Neogi T, Choi HK (2017) Editorial: do not let gout apathy lead to gouty arthropathy. Arthritis Rheumatol 69:479\u2013482","journal-title":"Arthritis Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-018-4065-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4065-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4065-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T20:48:32Z","timestamp":1552596512000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-018-4065-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,15]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["4065"],"URL":"https:\/\/doi.org\/10.1007\/s10067-018-4065-7","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2018,3,15]]},"assertion":[{"value":"12 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The ethics and research committees of both centers approved the study protocol. The study was conducted in accordance with the principles contained in the Declaration of Helsinki. All patients were informed about the procedures of the study and provided written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}